The Therapeutic Goods Administration (TGA) Approved PEMAZYRE (Pemigatinib)
Summary: Australia has authorised the use of a new targeted therapy for the treatment of cholangiocarcinoma, a rare bile duct cancer. The…
Summary: Australia has authorised the use of a new targeted therapy for the treatment of cholangiocarcinoma, a rare bile duct cancer. The…